- This patient would most likely be deemed unsuitable for out-patient treatment14.
- When using dalbavancin a full course of treatment can be administered without a PICC line with a single 30 minute infusion13.
- In the single dose study a total of 30.4%
of patients were intravenous drug users and 16.2% had hepatitis9.
Dalbavancin as a single-dose or 2-dose regimen had similar efficacy for the treatment of ABSSSI in persons who inject drugs (PWID) and non-PWID populations.